Akums Drugs & Pharmaceuticals
AKUMS · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 6, 2024

Stock Price vs Company Growth
1d
0.4%
1w
1.7%
1m
12.4%
3m
46.1%
6m
53.4%
1y
58.6%
all
2.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 748 0.4%
507
775
Company Overview

Sales
4,502 Cr
Growth: 6.6%
Profit after Tax
292 Cr
Growth: 14.3%
Mid Cap
11,768 Cr
P/E: 39.2x
Industry P/E: 31.7x
Fundamentals

Sales (Cr) ₹ 4,502
Growth 6.6%
EBITDA 12.6%
P/S 2.6x
Dividend 0.0%
P/E 39.2x
Book Value ₹ 217
PEG Ratio 5.9x
ROE 8.9%
P/B 3.4x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

As a CDMO, the company produces an extensive range of dosage forms including tablets, capsules, liquid orals, vials, ampoules, blow-filled seals, topical preparations, eye drops, dry powder injections, and gummies, among others. It also engages in the marketing of trade generic and products under its own brand through distributors and alternative channels across India. Key Awards and accreditations2018: Received India Pharma Leader Award by Government of India.
Followers (2)